At AstraZeneca, we know your health is personal and that’s why we put careful consideration into determining the value and ultimately the cost of our medicines. Many factors go into these decisions such as the benefits our medicines provide to your health and their potential to reduce healthcare spending on other costlier medical procedures. Just as importantly, these decisions enable us to invest in discovering and developing future medicines where new treatments are needed.
So how do we balance providing affordable access to our medicines while ensuring their cost reflects the value they deliver to the individual patient and broader healthcare system? We understand the weight of this question. That’s why we spend countless hours not just thinking about it, but finding new ways to help you and those you care about receive the best care possible for medical conditions we focus on. We do this by developing innovative medicines and offering programs that are uniquely tailored to you. We’re also always looking for ways to make your medicines more affordable and we collaborate with stakeholders across the healthcare system in pursuit of this goal.
Put differently – if you need our medicines, we want you to have affordable access to them and for them to make a valuable difference to your health. Here’s how we’re making medicine personal through innovation, support, and collaboration:
Through innovative approaches, patient support programs, and key collaborations within the health and biopharmaceutical industry, we’re making medicine personal to improve your health, your care, and your future.
Our medicines represent an important part of America’s healthcare dollar and it’s our job to show how these treatments can bring value to you and the entire healthcare system. In future blog posts, we look forward to sharing more about the value our treatments provide and what we are doing to improve their accessibility and affordability.
Biopharmaceutical companies, such as AstraZeneca, lead the way in improving patient health and advancing medical innovation. Find out more here.